Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2

Catalog No. :
ACLFYF566
CAS No. :
1092658-86-0
Molecular Formula :
C36H68N14O8
Molecular Weight :
825.03

IUPAC Name:(2S,3S)-2-((S)-2-((S)-2-(2-acetamidoacetamido)propanamido)-3-methylbutanamido)-N-((S)-1-(((S)-1-(((S)-1-amino-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-3-methylpentanamide

Ac-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAc-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2
IUPAC Name(2S,3S)-2-((S)-2-((S)-2-(2-acetamidoacetamido)propanamido)-3-methylbutanamido)-N-((S)-1-(((S)-1-(((S)-1-amino-5-guanidino-1-oxopentan-2-yl)amino)-5-guanidino-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)-3-methylpentanamide
Molecular FormulaC36H68N14O8
Molecular Weight825.03
SMILESCC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(C)=O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(N)=O
InChI KeyNJZWJYWUGVGZOH-ZPLLCTTDSA-N
SynonymAc-Gly-Ala-Val-Ile-Leu-Arg-Arg-NH2;L-Argininamide, N-acetylglycyl-L-alanyl-L-valyl-L-isoleucyl-L-leucyl-L-arginyl-
CAS No.1092658-86-0

Synthetic Route by SureRoute

1. ACLFYF566 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXLVB851 route compound structure diagram
    ACXLVB851543-24-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLFYF566 route product structure diagram
    ACLFYF5661092658-86-0
Inquiry

2. ACLFYF566 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWCKF025 route compound structure diagram
    ACWCKF02514975-30-5 In Stock
  4. Then
  5. ACLFYF566 route product structure diagram
    ACLFYF5661092658-86-0
Inquiry

Comments (0)